Skip to content
YCW24· Other

Granza Bio

Building programmable therapeutics for the immune system

ActiveChecked 20h ago
Batch
W24
Status, per YC
Active
Team size
8
HQ
San Francisco, CA
In W24248 companies, 83% AI
granzabio.comYC profile

Founders

Not read from YC yet; the weekly run fills these in.

Same space

About Granza Bio

Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed ammunition, Granza restores and enhances immune function. This approach enables a new class of treatments with the potential to transform diseases ranging from cancer to autoimmunity.

San Francisco, CA, USA

Granza Bio: questions

Which YC batch was Granza Bio in?

Granza Bio was in Y Combinator's Winter 2024 batch (W24).

Is Granza Bio still active?

Y Combinator lists Granza Bio as active.

Where is Granza Bio based?

Granza Bio lists San Francisco, CA, USA as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.

Weekly: new YC data, AI and devtools companies and status changes, Mondays.